Data | Título | Autor(es) | Tipo | Acesso |
6-Ago-2017 | AKT can modulate the in vitro response of HNSCC cells to irreversible EGFR inhibitors | Silva-Oliveira, Renato José; Melendez, Matias; Martinho, Olga, et al. | Artigo | Acesso aberto |
2016 | Anti-EGFR therapy: strategies in head and neck squamous cell carcinoma. | Oliveira-Silva, Renato J.; Carvalho, Ana-Carolina de; Viana, Luciano de Souza, et al. | Artigo | Acesso aberto |
31-Jan-2016 | Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker | Oliveira, Renato José Silva; Silva, Viviane Aline Oliveira; Martinho, Olga, et al. | Artigo | Acesso restrito autor |
Abr-2019 | EGF+61 A>G polymorphism is not associated with lung cancer risk in the Brazilian population | Laus, Ana Carolina; de Paula, Flavia Escremim; de Lima, Marcos Alves, et al. | Artigo | Acesso restrito UMinho |
Mar-2019 | Mutational profle of Brazilian lung adenocarcinoma unveils association of EGFR mutations with high Asian ancestry and independent prognostic role of KRAS mutations | Leal, Letícia Ferro; Paula, Flávia Escremim de; De Marchi, Pedro, et al. | Artigo | Acesso aberto |